1-244864047-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_031844.3(HNRNPU):​c.261G>A​(p.Glu87Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.243 in 1,608,226 control chromosomes in the GnomAD database, including 50,356 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.28 ( 6618 hom., cov: 33)
Exomes 𝑓: 0.24 ( 43738 hom. )

Consequence

HNRNPU
NM_031844.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.468

Publications

17 publications found
Variant links:
Genes affected
HNRNPU (HGNC:5048): (heterogeneous nuclear ribonucleoprotein U) This gene encodes a member of a family of proteins that bind nucleic acids and function in the formation of ribonucleoprotein complexes in the nucleus with heterogeneous nuclear RNA (hnRNA). The encoded protein has affinity for both RNA and DNA, and binds scaffold-attached region (SAR) DNA. Mutations in this gene have been associated with epileptic encephalopathy, early infantile, 54. A pseudogene of this gene has been identified on chromosome 14. [provided by RefSeq, Jun 2017]
HNRNPU Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 54
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 1-244864047-C-T is Benign according to our data. Variant chr1-244864047-C-T is described in ClinVar as [Benign]. Clinvar id is 586025.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.468 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.365 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HNRNPUNM_031844.3 linkc.261G>A p.Glu87Glu synonymous_variant Exon 1 of 14 ENST00000640218.2 NP_114032.2 Q00839-1Q96BA7
HNRNPUNM_004501.3 linkc.261G>A p.Glu87Glu synonymous_variant Exon 1 of 14 NP_004492.2 Q00839-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HNRNPUENST00000640218.2 linkc.261G>A p.Glu87Glu synonymous_variant Exon 1 of 14 1 NM_031844.3 ENSP00000491215.1 Q00839-1

Frequencies

GnomAD3 genomes
AF:
0.283
AC:
43049
AN:
151940
Hom.:
6601
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.370
Gnomad AMI
AF:
0.229
Gnomad AMR
AF:
0.347
Gnomad ASJ
AF:
0.234
Gnomad EAS
AF:
0.175
Gnomad SAS
AF:
0.201
Gnomad FIN
AF:
0.351
Gnomad MID
AF:
0.180
Gnomad NFE
AF:
0.224
Gnomad OTH
AF:
0.262
GnomAD2 exomes
AF:
0.271
AC:
63556
AN:
234182
AF XY:
0.261
show subpopulations
Gnomad AFR exome
AF:
0.374
Gnomad AMR exome
AF:
0.431
Gnomad ASJ exome
AF:
0.241
Gnomad EAS exome
AF:
0.183
Gnomad FIN exome
AF:
0.346
Gnomad NFE exome
AF:
0.225
Gnomad OTH exome
AF:
0.251
GnomAD4 exome
AF:
0.239
AC:
348360
AN:
1456170
Hom.:
43738
Cov.:
37
AF XY:
0.237
AC XY:
171824
AN XY:
724006
show subpopulations
African (AFR)
AF:
0.376
AC:
12541
AN:
33356
American (AMR)
AF:
0.422
AC:
18584
AN:
43998
Ashkenazi Jewish (ASJ)
AF:
0.240
AC:
6243
AN:
26008
East Asian (EAS)
AF:
0.140
AC:
5519
AN:
39460
South Asian (SAS)
AF:
0.223
AC:
19165
AN:
85796
European-Finnish (FIN)
AF:
0.338
AC:
17587
AN:
52100
Middle Eastern (MID)
AF:
0.214
AC:
1230
AN:
5758
European-Non Finnish (NFE)
AF:
0.228
AC:
252979
AN:
1109526
Other (OTH)
AF:
0.241
AC:
14512
AN:
60168
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
14886
29773
44659
59546
74432
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8924
17848
26772
35696
44620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.283
AC:
43090
AN:
152056
Hom.:
6618
Cov.:
33
AF XY:
0.287
AC XY:
21342
AN XY:
74292
show subpopulations
African (AFR)
AF:
0.370
AC:
15362
AN:
41484
American (AMR)
AF:
0.347
AC:
5313
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.234
AC:
811
AN:
3470
East Asian (EAS)
AF:
0.175
AC:
900
AN:
5146
South Asian (SAS)
AF:
0.201
AC:
966
AN:
4814
European-Finnish (FIN)
AF:
0.351
AC:
3714
AN:
10582
Middle Eastern (MID)
AF:
0.180
AC:
53
AN:
294
European-Non Finnish (NFE)
AF:
0.224
AC:
15215
AN:
67950
Other (OTH)
AF:
0.259
AC:
548
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
1462
2923
4385
5846
7308
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
418
836
1254
1672
2090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.240
Hom.:
1329
Bravo
AF:
0.290

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Apr 20, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 18, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Developmental and epileptic encephalopathy, 54 Benign:2
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jan 08, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.43
CADD
Benign
15
DANN
Benign
0.97
PhyloP100
-0.47
PromoterAI
-0.11
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6675421; hg19: chr1-245027349; COSMIC: COSV51690210; COSMIC: COSV51690210; API